That drop corresponds to an estimated 7 percent to 23 percent lower risk of cardiovascular events, shifting participants from the average-risk range into the low-risk range for heart disease, while the placebo group remained in the average-risk category
She recently denied an Ozempic prescription to a young patient who wanted to lose quick 4 kilograms (9 lbs) and already had doses of the drug from an unknown source.I told her she did not meet the criteria for the use and asked her to try it only at her own risk, Hooda said.In late 2017, Novo launched Ozempicthe GLP-1 drug that, while technically for diabetes, put weight-loss shots into the cultural consciousness
Whichever you choose, make sure it fits your body, your goals, and your long-term health
Put simply: if GLP-1 medication is appropriate for your individual situation, a decision only a licensed physician can make, Direct Meds provides a streamlined, medically supervised pathway to access it